
Frankie L. Stinson
Examiner (ID: 8117)
| Most Active Art Unit | 1746 |
| Art Unit(s) | 1792, 1711, 2402, 1746, 2899, 3405, 1743 |
| Total Applications | 3621 |
| Issued Applications | 3013 |
| Pending Applications | 138 |
| Abandoned Applications | 470 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13507621
[patent_doc_number] => 20180305353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => FUSED BICYCLIC HETEROCYCLE DERIVATIVES AS PESTICIDES
[patent_app_type] => utility
[patent_app_number] => 15/770738
[patent_app_country] => US
[patent_app_date] => 2016-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39654
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15770738
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/770738 | Fused bicyclic heterocycle derivatives as pesticides | Oct 20, 2016 | Issued |
Array
(
[id] => 12489825
[patent_doc_number] => 09994552
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-12
[patent_title] => Compositions useful for treating disorders related to kit
[patent_app_type] => utility
[patent_app_number] => 15/295450
[patent_app_country] => US
[patent_app_date] => 2016-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15421
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15295450
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/295450 | Compositions useful for treating disorders related to kit | Oct 16, 2016 | Issued |
Array
(
[id] => 13457651
[patent_doc_number] => 20180280368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-04
[patent_title] => 2-OXO-1,2-DIHYDROPYRIDINE-3,5-DICARBOXAMIDE COMPOUNDS AS BROMODOMAIN INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/766222
[patent_app_country] => US
[patent_app_date] => 2016-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25087
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15766222
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/766222 | 2-OXO-1,2-dihydropyridine-3,5-dicarboxamide compounds as bromodomain inhibitors | Oct 2, 2016 | Issued |
Array
(
[id] => 13065393
[patent_doc_number] => 10053469
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-21
[patent_title] => Pyridone and aza-pyridone compounds and methods of use
[patent_app_type] => utility
[patent_app_number] => 15/281923
[patent_app_country] => US
[patent_app_date] => 2016-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 110960
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 262
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15281923
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/281923 | Pyridone and aza-pyridone compounds and methods of use | Sep 29, 2016 | Issued |
Array
(
[id] => 12212087
[patent_doc_number] => 09908881
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-06
[patent_title] => 'Process for the preparation of apixaban and intermediates thereof'
[patent_app_type] => utility
[patent_app_number] => 15/282373
[patent_app_country] => US
[patent_app_date] => 2016-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8601
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15282373
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/282373 | Process for the preparation of apixaban and intermediates thereof | Sep 29, 2016 | Issued |
Array
(
[id] => 13492933
[patent_doc_number] => 20180298009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => Fused Pyrazole Derivatives As Kinase Inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/762670
[patent_app_country] => US
[patent_app_date] => 2016-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29906
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15762670
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/762670 | Fused Pyrazole Derivatives As Kinase Inhibitors | Sep 27, 2016 | Abandoned |
Array
(
[id] => 13427911
[patent_doc_number] => 20180265498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => 1,4-DI-(4-METHYLTHIOPHENYL)-3-PHTALOYLAZETIDINE-2-ONE AND THE DERIVATIVES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/762878
[patent_app_country] => US
[patent_app_date] => 2016-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15278
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15762878
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/762878 | 1,4-di-(4-methylthiophenyl)-3-phtaloylazetidine-2-one and the derivatives thereof | Sep 22, 2016 | Issued |
Array
(
[id] => 12260710
[patent_doc_number] => 20180079907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-22
[patent_title] => 'Stable Yellow Imidazolium Compounds'
[patent_app_type] => utility
[patent_app_number] => 15/267535
[patent_app_country] => US
[patent_app_date] => 2016-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21099
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15267535
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/267535 | Stable yellow imidazolium compounds | Sep 15, 2016 | Issued |
Array
(
[id] => 11514257
[patent_doc_number] => 20170081331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-23
[patent_title] => 'Pyrazolopyrazines and their use in the treatment, amelioration or prevention of a viral disease'
[patent_app_type] => utility
[patent_app_number] => 15/266224
[patent_app_country] => US
[patent_app_date] => 2016-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15164
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15266224
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/266224 | Pyrazolopyrazines and their use in the treatment, amelioration or prevention of a viral disease | Sep 14, 2016 | Abandoned |
Array
(
[id] => 11642152
[patent_doc_number] => 09663507
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2017-05-30
[patent_title] => 'Crystallisation of thiamine hydrochloride'
[patent_app_type] => utility
[patent_app_number] => 15/264042
[patent_app_country] => US
[patent_app_date] => 2016-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 2082
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15264042
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/264042 | Crystallisation of thiamine hydrochloride | Sep 12, 2016 | Issued |
Array
(
[id] => 11362810
[patent_doc_number] => 20170000791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-05
[patent_title] => 'MALEATE SALTS OF A QUINAZOLINE DERIVATIVE USEFUL AS AN ANTIANGIOGENIC AGENT'
[patent_app_type] => utility
[patent_app_number] => 15/264527
[patent_app_country] => US
[patent_app_date] => 2016-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10627
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15264527
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/264527 | Maleate salts of a quinazoline derivative useful as an antiangiogenic agent | Sep 12, 2016 | Issued |
Array
(
[id] => 13507511
[patent_doc_number] => 20180305298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => DEUTERATED CHLOROKYNURENINES FOR THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 15/767768
[patent_app_country] => US
[patent_app_date] => 2016-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13350
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15767768
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/767768 | DEUTERATED CHLOROKYNURENINES FOR THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS | Sep 7, 2016 | Abandoned |
Array
(
[id] => 11336643
[patent_doc_number] => 20160362396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-15
[patent_title] => 'QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/249710
[patent_app_country] => US
[patent_app_date] => 2016-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 153658
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15249710
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/249710 | Quinazolines as potassium ion channel inhibitors | Aug 28, 2016 | Issued |
Array
(
[id] => 14818321
[patent_doc_number] => 10406146
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-10
[patent_title] => Heterocyclic compound
[patent_app_type] => utility
[patent_app_number] => 15/754934
[patent_app_country] => US
[patent_app_date] => 2016-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21467
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15754934
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/754934 | Heterocyclic compound | Aug 23, 2016 | Issued |
Array
(
[id] => 11678245
[patent_doc_number] => 09676762
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-13
[patent_title] => 'Pyrimidine compounds containing seven-membered fused ring systems'
[patent_app_type] => utility
[patent_app_number] => 15/245854
[patent_app_country] => US
[patent_app_date] => 2016-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19587
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15245854
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/245854 | Pyrimidine compounds containing seven-membered fused ring systems | Aug 23, 2016 | Issued |
Array
(
[id] => 13386173
[patent_doc_number] => 20180244628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-30
[patent_title] => CRYSTALLINE FORM OF ANDROGEN RECEPTOR INHIBITOR AND PREPARATION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/757652
[patent_app_country] => US
[patent_app_date] => 2016-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3534
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15757652
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/757652 | Crystalline form of androgen receptor inhibitor and preparation method thereof | Aug 22, 2016 | Issued |
Array
(
[id] => 12215110
[patent_doc_number] => 09911929
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-06
[patent_title] => 'Light emitting compounds'
[patent_app_type] => utility
[patent_app_number] => 15/239160
[patent_app_country] => US
[patent_app_date] => 2016-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13207
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15239160
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/239160 | Light emitting compounds | Aug 16, 2016 | Issued |
Array
(
[id] => 15663905
[patent_doc_number] => 10596159
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-24
[patent_title] => Method and composition for treating cachexia and eating disorders
[patent_app_type] => utility
[patent_app_number] => 15/751901
[patent_app_country] => US
[patent_app_date] => 2016-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1556
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15751901
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/751901 | Method and composition for treating cachexia and eating disorders | Aug 10, 2016 | Issued |
Array
(
[id] => 13357241
[patent_doc_number] => 20180230160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-16
[patent_title] => 2-AMINO-7A-PHENYL-3,4,4A,5,7,7A-HEXAHYDROFURO[3,4-B]PYRIDINES AS BACE1 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/751777
[patent_app_country] => US
[patent_app_date] => 2016-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16717
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15751777
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/751777 | 2-AMINO-7A-PHENYL-3,4,4A,5,7,7A-HEXAHYDROFURO[3,4-B]PYRIDINES AS BACE1 INHIBITORS | Aug 9, 2016 | Abandoned |
Array
(
[id] => 11515571
[patent_doc_number] => 20170082645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-23
[patent_title] => 'NEAR-INFRARED FLUORESCENT SENSORS FOR BIOLOGICAL AMINES'
[patent_app_type] => utility
[patent_app_number] => 15/229716
[patent_app_country] => US
[patent_app_date] => 2016-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7344
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15229716
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/229716 | Near-infrared fluorescent sensors for biological amines | Aug 4, 2016 | Issued |